HUM-MOLGEN events: Cambridge Healthtech Institute's GLYCOMICS Conference

HUM-MOLGEN -> Events -> Meetings and Conferences

Cambridge Healthtech Institute's GLYCOMICS Conference

January 28, 2003

Cambridge Healthtech Institute, University Hotel @ MIT, 20 Sidney Street, Cambridge, MA 02139
May 5-6, 2003

Carbohydrate modification of proteins and lipids is the functional fine-tuning of these molecules. It is not surprising therefore that errors in glycosylation have severe implications and are found associated with common diseases such as cancer and diabetes.
Carbohydrates have historically been desirable targets for drug intervention but success stories have been limited. Recent advances in synthetic and analytical methods are facilitating a better understanding the role of glyco-protein and carbohydrates in many cellular and signaling processes and paving the way for carbohydrate drug discovery.

This conference will showcase many of the technical advances in glycobiology and carbohydrate chemistry that have been made recently along with several case studies of applications in drug development ranging from carbohydrate based compounds to modifications of recombinant bio-molecules for drug delivery.

Glycomics Tutorial: Monday May 5, 9-12:00
Glycomics - Technological Breakthroughs Pave the Way to the Next Wave in Biotechnology
Peter H. Seeberger, Firmenich Associate Professor of Chemistry,
Massachusetts Institute of Technology

Topics to be Covered:
High-Throughput Methods for Analyzing Carbohydrate and Glycoprotein Structure
Methods for Synthesizing Carbohydrates including Enzymatic and Organic
Carbohydrate-Based Drugs | Carbohydrates in Drug Delivery
Carbohydrates as Biomarkers for Disease | Glycosylation

Organized by:

Cambridge Healthtech Institute

Invited Speakers:

Scientific Advisory Board
Dr. Prabhat Arya, National Research Council of Canada
Dr. Tillman Gerngross, GlycoFi, Inc.
Dr. Ram Sasisekharan, MIT
Dr. Frank Schweizer, The University of Manitoba
Dr. Peter H. Seeberger, Massachusetts Institute of Technology
Dr. Ganesh Venkataraman, Momenta Pharmaceuticals Inc.

Deadline for Abstracts:

April 4, 2003

Registration:

Available Online Call: 617-630-1300, Fax: 617-630-1325 e-mail:chi@healthtech.com

E-mail:

eeskedal@healthtech.com

Posted by:

elaine eskedal

Host:

wks152.healthtech.com